Advertisement
Advertisement

CVS

CVS logo

CVS HEALTH CORPORATION

78.78
USD
Sponsored
+0.56
+0.71%
Apr 08, 16:00 UTC -4
Closed
exchange

After-Market

78.31

-0.46
-0.59%

CVS Earnings Reports

Positive Surprise Ratio

CVS beat 38 of 40 last estimates.

95%

Next Report

Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$95.92B
/
$2.25
Implied change from Q4 25 (Revenue/ EPS)
-9.25%
/
+106.42%
Implied change from Q1 25 (Revenue/ EPS)
+1.40%
/
--

CVS HEALTH CORPORATION earnings per share and revenue

On Feb 10, 2026, CVS reported earnings of 1.09 USD per share (EPS) for Q4 25, beating the estimate of 1.00 USD, resulting in a 8.80% surprise. Revenue reached 105.69 billion, compared to an expected 104.63 billion, with a 1.02% difference. The market reacted with a -0.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 20 analysts forecast an EPS of 2.25 USD, with revenue projected to reach 95.92 billion USD, implying an increase of 106.42% EPS, and decrease of -9.25% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+15.51%
logo
So-Young International Inc. - ADR
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.70
Actual
-$0.93
Surprise
-32.59%
logo
OSR Holdings, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.16
Surprise
-56.86%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
logo
Synergy CHC Corp. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
$0.01
Actual
-$0.72
Surprise
-7158.82%
logo
Co-Diagnostics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$3.67
Actual
-$3.64
Surprise
+0.87%
FAQ
For Q4 2025, CVS HEALTH CORPORATION reported EPS of $1.09, beating estimates by 8.8%, and revenue of $105.69B, 1.02% above expectations.
The stock price moved down -0.09%, changed from $75.77 before the earnings release to $75.70 the day after.
The next earning report is scheduled for May 06, 2026.
Based on 20 analysts, CVS HEALTH CORPORATION is expected to report EPS of $2.25 and revenue of $95.92B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement